Investor RelationsFinancial Highlights / Segment and Regional Information
Consolidated Financial Results
| '21/3 | '22/3 | '23/3 | '24/3 | |
|---|---|---|---|---|
| Net sales | 455,559 | 494,789 | 545,199 | 586,785 |
| Operating incomeOperating income ratio (%) | 27,6276.1 | 23,8824.8 | 17,7293.3 | 22,3353.8 |
| Ordinary incomeOrdinary income ratio (%) | 26,2695.8 | 27,5835.6 | 15,3462.8 | 19,5093.3 |
| Net incomeNet income ratio (%) | 14,2093.1 | 13,4552.7 | 4,5740.8 | 11,1091.9 |
| Basic earnings per share (Unit: yen) | 87.12 | 82.50 | 28.05 | 68.12 |
| Cash dividends per share (Unit: yen) | 28.0 | 27.0 | 22.0 | 25.0 |
| Dividend payout ratio (%) | 32.1 | 32.7 | 78.4 | 36.7 |
| Net assetsReturn on equity (%) | 174,0539.2 | 199,8677.8 | 242,1732.3 | 269,7885.1 |
| Total assetsEquity ratio (%) | 854,39618.8 | 930,32119.9 | 1,027,39920.1 | 1,109,82121.0 |
| Capital expenditures | 51,982 | 46,560 | 95,991 | 9,585 |
| Depreciation and amortization | 39,849 | 43,313 | 46,275 | 56,030 |
Net Sales
Unit: Billions of yen
Operating Income / Operating Income Ratio
Unit: Billions of yenUnit: %
Ordinary Income / Ordinary Income Ratio
Unit: Billions of yenUnit: %
Net Income / Net Income Ratio
Unit: Billions of yenUnit: %
Basic Earnings per Share
Unit: yen
Cash Dividends per Share
Unit: yen
Net Assets
Unit: Billions of yen
Total Assets
Unit: Billions of yen
Return on Equity
Unit: %
Equity Ratio
Unit: %
Capital Expenditures
Unit: Billions of yen
Depreciation and Amortization
Unit: Billions of yen
Consolidated Financial Results by Business Segment - Net Sales
| Medical-Related | Pharmaceutical-Related | PharmaPackaging | Other | Total | |
|---|---|---|---|---|---|
| '21/3 | 343,824 | 72,388 | 38,655 | 691 | 455,559 |
| '22/3 | 373,481 | 74,386 | 46,361 | 559 | 494,789 |
| ‘23/3 | 419,957 | 72,734 | 51,754 | 752 | 545,199 |
| ‘24/3 | 453,613 | 74,320 | 58,035 | 816 | 586,785 |
Unit: Billions of yen
* Clicking on a legend item in the graph hides that item in the graph. Multiple legends can also be hidden.
Clicking on the legend item again will make the hidden item reappear.
Consolidated Financial Results by Business Segment - Operating Income
| Medical-Related | Pharmaceutical-Related | PharmaPackaging | Other | Adjustment | Total | |
|---|---|---|---|---|---|---|
| '21/3 | 38,879 | 10,608 | 1,992 | 376 | -24,229 | 27,627 |
| '22/3 | 39,241 | 9,826 | 2,889 | 101 | -28,175 | 23,882 |
| ‘23/3 | 38,599 | 5,615 | 2,739 | 257 | -29,482 | 17,729 |
| ‘24/3 | 42,321 | 4,432 | 2,452 | 80 | -26,952 | 22,335 |
Unit: Billions of yen
* Clicking on a legend item in the graph hides that item in the graph. Multiple legends can also be hidden.
Clicking on the legend item again will make the hidden item reappear.
Net Sales by Region
| Japan | America | Europe | Asia | Total | |||||
|---|---|---|---|---|---|---|---|---|---|
| Net sales | Proportion | Net sales | Proportion | Net sales | Proportion | Net sales | Proportion | Net sales | |
| '21/3 | 270,543 | 59.4% | 71,572 | 15.7% | 52,167 | 11.5% | 61,275 | 13.5% | 455,559 |
| '22/3 | 280,094 | 56.6% | 78,242 | 15.8% | 60,376 | 12.2% | 76,075 | 15.4% | 494,789 |
| '23/3 | 290,177 | 53.2% | 98,089 | 18.0% | 68,294 | 12.5% | 88,636 | 16.3% | 545,199 |
| '24/3 | 304,602 | 51.9% | 108,018 | 18.4% | 77,203 | 13.2% | 96,961 | 16.5% | 586,785 |
Unit: Billions of yen
* Clicking on a legend item in the graph hides that item in the graph. Multiple legends can also be hidden.
Clicking on the legend item again will make the hidden item reappear.
Proportion of Net Sales by Region (2024/3)
Unit: %